Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...

Boston Scientific Corp. BSX 0.67% has agreed to buy British health-care firm BTG PLC for £3.3 billion ($4.24 billion), bolstering its presence in the growing field of interventional medicine ...

Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as BTG plc ( LON:BTG ), with a market cap of UK£2.01b, often get neglected by retail investors.

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

BTG plc (LSE:BTG) is trading with a trailing P/E of 35.6x, which is higher than the industry average of 33.1x. While BTG might seem like a stock to avoid or sell if you own it, it is important to ...

A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability ...

Boston Scientific Corp. BSX said Tuesday that it has agreed to a takeover bid for U.K. specialty health-care company BTG PLC (BTG.LN) in a deal worth 3.3 billion pounds ($4.23 billion). The ...

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...

Shares of BTG PLC (BTG.LN) fell in early trade Friday after the health-care company said that a U.S. Food & Drug Administration panel has voted against the approval of its Elevair Endobronchial ...

BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to ...

Galil Medical Inc., a developer of cryoablation products for the treatment of kidney and other cancers, has agreed to be acquired by specialist health-care company BTG PLC. BTG will pay $84.5 ...

BTG Plc, a London-based specialty pharmaceutical company, won U.S. approval for its drug to combat the toxic effects of a cancer treatment. The Food and Drug Administration cleared the medicine to ...